Hacker News new | past | comments | ask | show | jobs | submit login

> AstraZeneca are selling their vaccine at cost.

There is a difference between accounting profit (receipts vs outlays) vs economic profit (benefits of doing something vs opportunity cost of doing it).

It is almost tautological that there is nothing to gain for the people involved in the vaccine food chain from limiting the scope of the government-cajoled "market" for them but acknowledging that natural immunity does exist and is stronger than what the vaccine-provided protection.

Therefore, the statement:

>> SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021.

> "There is, of course, no profit or gold-plated post civil "service" career in big pharma or book deals associated with acknowledging this."

does not refer to the balance sheet of AstraZeneca or any other company. It refers to the prospective incentives of people involved in the vaccine food chain.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: